Phase I-II trial of percutaneous intra-arterial Cis-diamminedichloro platinum (II) for regionally confined malignancy
D. B. Calvo(The University of Texas System), Giora M. Mavligit(The University of Texas System), Yehuda Z. Patt(Anderson Hospital), E. M. Hersh(Arizona Oncology), V. P. Chuang(The University of Texas System), G. P. Bodey(The University of Texas MD Anderson Cancer Center), J. D. Pritchard(Anderson Hospital), S Wallace(The University of Texas System), Robert S. Benjamin(The University of Texas MD Anderson Cancer Center)
Cited by 103
Related Papers
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
|The Journal of Infectious Diseases|1985|408
Pseudomonas bacteremia. Retrospective analysis of 410 episodes
|Archives of Internal Medicine|1985|361
Systemic candidiasis in cancer patients.
|PubMed|1984|272